10 min listen
Hydroxychloroquine Questions
FromAxios Re:Cap
ratings:
Length:
9 minutes
Released:
Apr 9, 2020
Format:
Podcast episode
Description
Hydroxychloroquine has evolved from a sleepy anti-malaria drug into a partisan litmus test over the future of COVID-19 treatment. Dan and Axios healthcare reporter Bob Herman dig into what we know about the drug, what we still don't, and why both matter.
PLUS: New money for small businesses and a way to help New York medical workers
PLUS: New money for small businesses and a way to help New York medical workers
Released:
Apr 9, 2020
Format:
Podcast episode
Titles in the series (100)
Everyone unfriends Facebook by Axios Re:Cap